Toxin A but not toxin B, appears to mediate intestinal damage in animal models of Clostridium difficile enteritis. The purpose of this study was to investigate the electrophysiologic and morphologic effects of purified C. difficile toxins A and B on human colonic mucosa in Ussing chambers. Luminal exposure of tissues to 16-65 nM of toxin A and 0.2-29 nM of toxin B for 5 h caused dose-dependent epithelial damage. Potential difference, short-circuit current and resistance decreased by 76, 58, and 46%, respectively, with 32 nM of toxin A and by 76, 55, and 47%, respectively, with 3 nM of toxin B, when compared with baseline (P < 0.05). 3 nM of toxin A did not cause electrophysiologic changes. Permeability to [3H]mannitol increased 16-fold after exposure to 32 nM of toxin A and to 3 nM of toxin B when compared with controls (P < 0.05). Light and scanning electron microscopy after exposure to either toxin revealed patchy damage and exfoliation of superficial epithelial cells, while crypt epithelium remained intact. Fluorescent microscopy of phalloidin-stained sections showed that both toxins caused disruption and condensation of cellular F-actin. Our results demonstrate that the human colon is approximately 10 times more sensitive to the damaging effects of toxin B than toxin A, suggesting that toxin B may be more important than toxin A in […] 76, 55, and 47%, respectively, with 3 nM of toxin B, when compared with baseline (P < 0.05).
Introduction
Clostridium difficile, the causative agent of antibiotic-associated colitis in animals (1, 2) and humans (3, 4) , releases two high molecular weight exotoxins: toxin A and toxin B (5, 6) . Although numerous animal studies have shown that C. difficile colitis is toxin-mediated, the exact role of toxin A and B in pathogenesis, especially in humans, remains unclear. Both toxins possess cytotoxic activity against a variety of cultured cells (6) (7) (8) (9) and cause death when injected parenterally in laboratory animals (10). However, experiments in rabbits (11, 12) , rats (13) , mice (14) , and hamsters (15) suggest that only toxin A is capable of damaging the intestinal mucosa in vivo. For example, previous in vivo studies demonstrated that toxin A, but not toxin B, caused severe inflammation, epithelial damage and fluid secretion when injected into rabbit ileal loops in vivo (11, 12) . Mitchell et al. showed that toxin A caused epithelial damage in rabbit colon, while toxin B had no effect (11) . Lyerly et al. also reported that intragastric administration of toxin A, but not toxin B, to hamsters and mice caused hemorrhagic secretion in the small intestine unless the bowel was first damaged before toxin B exposure (15) . Moreover, hamsters immunized against toxin B alone were not protected from clindamycin colitis, whereas animals immunized against toxin A, or a combination of toxins A and B were protected (16) . Taken together, these results indicate that toxin A causes intestinal damage in animal models, while toxin B is innocuous when placed in the lumen.
While lacking an enterotoxic effect in experimental animals, toxin B is extremely cytotoxic to cultured mammalian cells (6, 17) , including those derived from the human intestine (19 (20) , perturbs the cytoskeleton of human colonic cancer T84 cell monolayers causing an increase in permeability and a decrease in transepithelial resistance. However, the possibility remains that the T84 cell-line derived from a colonic adenocarcinoma does not accurately reflect the response of the normal human colon to toxin B.
The purpose of this study was to compare the effects of highly purified toxins A and B on human colonic mucosa mounted in Ussing chambers. We report here that toxins A and B disrupt the epithelial barrier and cause epithelial cell necrosis and electrophysiologic changes of the human colon in vitro, but that toxin B is more effective than toxin A in producing these effects.
Methods
Toxin preparation. Toxins A and B were purified to homogeneity as previously described (6, 21) . Enterotoxic activity of toxin A was assayed in rat ileal loops (22-24) and cytotoxic activity of both toxins was tested against IMR-90 fibroblasts as previously (6, 21) . Purity of toxins A and B were determined by SDS-PAGE (6, 21 a total of 50 individual specimens of histologic tumor-free sigmoid colon was used. After removal of the seromuscular layer by blunt dissection 1-5 mucosal sheets from each specimen measuring 4-10 cm2 were mounted horizontally in custom-made incubation chambers with the luminal surface (1 cm2 surface area) facing upwards as previously described (27 Morphometry. After Ussing chamber experiments tissues were processed for light microscopy. Mucosal damage was assessed by an histopathologist (R. Sedivy), who performed morphometry on coded, paraffin embedded, H&E stained slides as previously described (27) , and was "blinded" as to the experimental conditions to which a particular tissue had been exposed. The surface area of each tissue mounted into chambers was 1 X 1 cm. Morphometry was performed on nine vertical sections from different locations each of which representing the total height and length (1 cm) of the mucosal preparation. Thus a total length of 8-9 cm of mucosal surface was examined for each tissue. We used a Leitz Diaplan research microscope ( Histological criteria for epithelial damage were: reduced staining intensity of epithelial cells, karyopyknosis, karyolysis and karyorrhexis, cell disruption, formation of subepithelial blebs and lifting off of cells from the basal lamina (27) .
Fluorescent microscopy. Fluorescent staining of F actin was performed using rhodamine-labeled phalloidin (Molecular Probes, Inc., Eugene, OR) on fresh-frozen tissue. Sections (4 ,um) were fixed in 4% paraformaldehyde (pH 8.0), washed in phosphate buffered saline solution (pH 8.0; PBS) and incubated for 45 min. Subsequently, slides were mounted with Glycerol:PBS/ 1:9 and examined and photographed using a Zeiss Axiophot fluorescence microscope.
Processing for scanning electron microscopy (SEM). Tissues were washed in 0.1 M cacodylate buffer pH 7.3 and postfixed for 90 min in the same buffer containing 1.0% buffered osmium tetroxide. Samples 1. Abbreviations used in this paper: Isc, short circuit current; PD, potential difference; R, resistance. 
Results
Toxin effects on electrophysiology. The effects of toxins A and B on colonic electrophysiology were compared using potential difference (PD), short-circuit current (Isc), and electrical resistance (R). Both toxins caused a time-dependent decrease of electrophysiologic parameters. The time course effect of 32 nM of toxin A is shown in Fig. 1 . Luminal toxin exposure caused a rapid decline of resistance that became statistically significant after 2 h of toxin exposure (P < 0.05), and continued to decline until the end of the 5-h observation period (n = 6). A similar progressive decline of resistance was observed in tissues exposed to 16 nM of toxin A, which became significantly different from controls 3 h (P < 0.05) after toxin administration (data not shown).
We next compared the effects of different doses of toxins A and B on electrophysiological parameters. As shown in Table  I , PD, Isc and R remained stable for up to 5 h in the control strips incubated with buffer alone. In contrast, luminal exposure of mucosal strips to 65, 32, and 16 nM of toxin A or 15, 3, and 1.5 nM of toxin B for 5 h caused a significant dose-dependent decrease in all parameters tested as compared to baseline values. For each data set, we compared the effects of toxins to the baseline value for the same colonic strip derived prior to addition of toxins. As shown in Table I , considerable variability in baseline values for all parameters was observed in tissues from different patients. Toxin B was 10 times more potent than toxin A on a molar basis in producing a comparable drop in resistance (Table I, Fig. 2 ). Because, as noted above, tissues from individual patients exhibited considerable variation in baseline electrophysiologic parameters, we carried out experiments where mucosal strips from the same patient were exposed to toxins A and B. As shown in Fig. 3, 3 nM of toxin B caused an immediate decline of resistance, which became statistically significant after 1 h (P < 0.05), while 3 nM of toxin A failed to show an effect (n = 4, paired tissues). Resistance further declined in the 3 nM toxin B group until the end of the experiments (Fig. 3) .
Permeability to [3Hlmannitol. We next investigated the effect of various doses of toxins A and B on serosal to mucosal permeability to [3H]mannitol (Fig. 4) Histology. No tissue strips used in these experiments showed histological criteria of malignancy. Histologic examination of colonic strips incubated with buffer alone for 5 h showed excellent preservation of normal colonic architecture (Fig. 5 A) . Toxins A and B exerted similar histologic changes depending on the concentration. The primary effect of both toxins was exerted on superficial epithelial cells whereas the epithelium of the crypts remained intact (Fig. 5 B, toxin A, 32 nM and SC, toxin B, 3 nM). A typical histologic finding was a patchy distribution of the lesions, resulting in appearance of intact epithelium adjacent to severely damaged areas (Fig. 5 D) . After toxin A or toxin B exposure, histologic examination revealed flat epithelial cells with regular staining intensity covering the basal lamina propria in the damaged areas (Fig. 5 D, arrow) . These colonocytes had flattened nuclei which were oriented parallel to the basal lamina propria (Fig. 5 D) .
Toxin-mediated morphologic damage expressed as the percent of damaged mucosa was dose-dependent (Fig. 6 ). Again toxin B was 8-10 times more potent than toxin A on a molar basis. While 3 nM of toxin B caused mucosal damage of 31%, 3 nM of toxin A had no effect (Fig. 6) . At the lowest concentration of toxin B used in these studies (0.2 nM) we observed morphologic damage to single cells (Fig. 7, A and C) . At 3 nM of toxin B scanning electron microscopy revealed widespread damage of superficial colonic epithelial cells (Fig. 7 D) . Distribution ofF-Actin. In previous studies we reported that purified toxins A and B caused a marked decrease in fluorescent staining for F-actin in monolayers of the T84 colonic adenocarcinoma cell line (19, 20) . We therefore assessed the effect of toxins A and B on F-actin distribution in human colonic strips. Control cells had a polygonal shape with F-actin distributed in the peripheral actinomyosin ring associated with the cell membrane (Fig. 8 A) . In contrast, tissues treated with toxin B for 5 h showed complete disorganization of the normal F-actin pattern with clumping of actin within cells (Fig. 8 B) . Similar alterations of intracellular F-actin were seen in tissues treated with toxin A (data not shown).
Discussion
In this in vitro study we strips in Ussing chambers. Toxin exposure caused an immediate decrease of resistance ( Figs. 1 and 2 ) which became statistically significant within 1-3 h of toxin exposure. This is in contrast to our previous results obtained with T84 cells (19) which showed that a latency period of 1-2 h occurred between toxin exposure and the onset of an electrophysiologic effect. While toxin A was more potent than toxin B in all previous studies in experimental animals, we report here for the first time that toxin B is -10-fold more potent on a molar basis than toxin A in human mucosa (Table I, Fig. 2 ). For example, we previously reported that in T84 cells toxin A at a concentration of 0.2 nM caused a resistance drop of 80% at 72 h (20) , compared with toxin B which caused the same effect at a concentration of 2.5 nM ( 19). As reported here (Fig. 2) resistance was decreased by 46% at a toxin A concentration of 32 nM whereas only 3 nM toxin B was required to produce a similar decrease (Table I, Fig. 3 ). These differences in relative sensitivity to toxins probably reflect differences between neoplastic T84 cells vs. normal intestinal strips, as well as methodological differences between cell-lines and tissue strips in a chamber. One limitation of Ussing chamber experiments is that the maximum period of observation is 6 h after which time necrosis of tissue ensues. For this reason, higher concentrations of toxins are required to produce an effect within a few hours, while in the T84 cell system continuous observation for 2 or 3 d are possible, thus allowing lower toxin doses. In these experiments reported here we used concentrations of toxin A or B ranging between 0.2 and 65 nM. Similar doses of toxin A (6-30 nM) were required in previous experiments to produce an acute inflammatory and secretory response in rat ileal loops in vivo ( 12) . However, since no detailed studies are available regarding the concentration of either toxin in stools from patients with C. difficile colitis, the relationship between our in vitro results and actual C. difficile infection in patients remains speculative.
Our previous results (20) on cultured human intestinal T84 cell monolayers indicate that electrical resistance changes in response to toxin A are a more sensitive indicator of barrier function than mannitol flux. In T84 cells, large changes in serosal-to-mucosal fluxes in response to toxin A were observed only after resistance was maximally affected (e.g., 3-4-fold decrease). Similarly in this study, mannitol fluxes were not correlated directly with maximal resistance changes at 5 h. For example, exposure of colonic explants to 32 nM toxin A or 1.5 nM toxin B produced an equivalent drop in resistance to 95 Ohm x cm2 at 5 h (Table I) . Despite these nearly identical resistance values, mannitol fluxes were nearly threefold higher in the explants exposed to 32 nM toxin A vs. 1.5 nM toxin B. Some of this discrepancy possibly relates to a difference in the time of onset and rate of decline of resistance changes at varying toxin concentrations. Although the final resistance might be identical at 5 h, mannitol fluxes over the entire 5-h period might vary considerably. However, measurement of mannitol fluxes over consecutive 15-or 30-min periods might reveal closer correlation with resistance changes.
In contrast to earlier animal studies where toxin A was reported to cause diffuse mucosal damage (12, 13, 23, 24) , we report here that toxins A and B cause patchy or even discrete single cell lesions in human colon depending on the toxin concentration. At lower toxin doses epithelial cell damage is patchy, but becomes more confluent at higher doses (Figs. 5-7 ). This finding may correlate with the variability of colonic pseudomembrane observed in patients with antibiotic-associated colitis secondary to C. difficile. In some patients with C. difficile colitis pseudomembranes are discrete, while in others the membrane and subjacent inflammatory response may cover the entire mucosal surface. Our in vitro results suggest that the extent of colonic damage is related to the toxin concentrations and the duration of exposure before diagnosis. We observed in our study that both toxins caused damage of superficial epithelial cells while crypt epithelium remained intact ( Fig. 5 and 7 ). This finding could be explained by a different distribution of toxin A and B receptors on mucosal epithelium. For example, we have previously reported that binding of biotinylated toxin A to rabbit ileum was limited to the brush border of villus tip cells with no binding on the crypt epithelial cells (28) . Conceivably, a similar distribution of toxin A or B receptors in superficial vs. crypt colonocytes may explain the absence of damage to crypt cells compared with the extensive necrosis observed in superficial epithelial cells.
A possible explanation for the lack of intestinal effects of toxin B in animal models (11, 12, 15) is absence of receptor binding sites for this toxin in rodent intestine. Previous studies have suggested a strong correlation between presence of membrane receptors for either toxin A or toxin B and biologic responsiveness to these toxins. For example Rolfe (29) , using radiolabeled toxin B, failed to show any toxin B specific binding sites for this toxin in hamster intestine, a tissue known to be insensitive to toxin B (15) . Conversely, hamster and rabbit intestine possess specific toxin A brush border receptors and both tissues are sensitive to the intestinal effects of toxin A ( 11, 12, 15, 29) . In addition, diminished toxin A receptor binding activity in newborn rabbit ileum was associated with a substantial reduction in biologic effect, while developmental increase in receptor activity from birth to age 24 d was associated with acquisition of toxin sensitivity (28) . Although binding activity was not measured in the present study, our results imply that receptors for both toxins are present in the luminal aspect of colonocytes.
We observed disruption and clumping of actin in colonocytes exposed to toxin B (Fig. 8 ) similar to changes reported previously by us in guinea pig ileum (30) and in human T 84 colonic cells (19, 20) . In human fibroblast cell lines the level of filamentous actin declined prior to cell rounding (6) . The action of these toxins on filamentous actin in target cells is most likely related to the catalytic action of toxins on Rho A and B, small GTP-binding proteins known to be involved in actin filament assembly (31) . The similarity of action of toxins A and B in the human colon is not surprising based on their striking amino acid homology (25, 26) .
The mechanism by which toxins A and B damage the human intestine can be categorized as direct and indirect. Direct toxicity occurs when cultured cells are exposed to toxins A and B, and presumably occurs via toxin binding, internalization (17) and disruption of the cytoskeleton with eventual inhibition of protein synthesis (18) and cell division. Part of the intestinal effects of toxin A described in ileal loop studies results from indirect activation of lamina propria neuroimmune cells (23, 24, (32) (33) (34) (35) and infiltration of the ileal submucosa by neutrophils (23, 24, 35, 36) . In the experiments reported here we assume that the immediate onset of electrophysiological changes after luminal toxin exposure suggests direct damage, although we can not exclude the release of cytokines, prostanoids or other pro-inflammatory mediators from lamina propria immune cells present in these mucosal strips. Studies are underway to define the possible contribution of epithelial and nonepithelial cells to the toxin effects described here.
